PRESS RELEASE published on 12/09/2024 at 08:00, 1 year 6 months ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC announces the purchase of 63,422 ordinary shares as part of the share buyback program. Details of transactions and impact on voting rights included Voting Rights Ordinary Shares Share Buyback Program Euronext Dublin Dalata Hotel Group
BRIEF published on 12/06/2024 at 14:44, 1 year 6 months ago Dalata Hotel Group PLC: Notification of Major Holdings by UBS Voting Rights Major Holdings Notification Financial Instruments Dalata Hotel Group UBS Group AG
BRIEF published on 12/06/2024 at 14:44, 1 year 6 months ago Dalata Hotel Group PLC : Notification de participations importantes par UBS Droit De Vote Instruments Financiers Groupe Hôtelier Dalata UBS Group SA Notification Des Participations Principales
PRESS RELEASE published on 12/06/2024 at 14:39, 1 year 6 months ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* UBS Investment Bank & Wealth Management crosses 4% ownership threshold in Dalata Hotel Group PLC. Notification of major holdings according to TR-1 form submitted on 06-Dec-2024 Acquisition Dalata Hotel Group TR-1 Form Investment Bank UBS
BRIEF published on 12/06/2024 at 12:00, 1 year 6 months ago UBS Adjusts Holdings in Dalata Hotel Group PLC Voting Rights Major Shareholding Financial Instruments Dalata Hotel Group UBS Holdings
BRIEF published on 12/06/2024 at 12:00, 1 year 6 months ago UBS ajuste ses participations dans Dalata Hotel Group PLC Droit De Vote Instruments Financiers Participation Majoritaire Groupe Hôtelier Dalata UBS Holdings
PRESS RELEASE published on 12/06/2024 at 11:55, 1 year 6 months ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* UBS Group AG - UBS Investment Bank & Wealth Management crosses 4% threshold for financial instruments in Dalata Hotel Group PLC Notification Dalata Hotel Group Plc Threshold Financial Instruments UBS Group AG
BRIEF published on 12/06/2024 at 08:05, 1 year 6 months ago Dalata Hotel Group Executes Share Buyback Voting Rights Ordinary Shares Share Buyback Financial Strategy Dalata Hotel Group
BRIEF published on 12/06/2024 at 08:05, 1 year 6 months ago Le groupe hôtelier Dalata procède à un rachat d'actions Rachat D'actions Stratégie Financière Droit De Vote Actions Ordinaires Groupe Hôtelier Dalata
PRESS RELEASE published on 12/06/2024 at 08:00, 1 year 6 months ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC announces the purchase of 97,157 ordinary shares as part of the Share Buyback Programme. Shares will be cancelled, resulting in 213,240,774 voting rights Voting Rights Ordinary Shares Share Buyback Programme Dalata Hotel Group Plc EUR 0.01
Published on 06/26/2026 at 14:05, 3 hours 40 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 45 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 45 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 17:05, 40 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 45 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 16:38, 1 hour 7 minutes ago Cairn Homes Plc: Notice of H1 2026 Trading Update
Published on 06/26/2026 at 15:30, 2 hours 15 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 2 hours 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 45 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 45 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
